Prolacta Bioscience Inc.
Prolacta Bioscience Inc. (Prolacta) is a privately held pharmaceutical company. It is principally engaged in improving the quality of life in the most fragile infants. The company is primarily focused in creating specialty formulations made from human milk by utilizing the state-of-the-art formulation, pasteurization and filling processes for the nutritional needs of critically ill and premature infants in the neonatal intensive care unit (NICU). In addition, the company mainly focuses on offering the human milk-based nutritional products. The products offered by the company include human milk fortifier and standardized human milk. The company is in the research and development of Prolacta and developed a human-sourced, liquid fortifier (Prolact+ H2MF). The company is headquartered at Monrovia in California, the US.